(Q38482214)

3 September 2017

Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives (English)

1 reference

3 September 2017

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325232%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Maria Dalamaga

series ordinal

1

1 reference

3 September 2017

1 January 2014

1 reference

3 September 2017

Biomarkers in Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325232%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325232%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325232%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

107-118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325232%20AND%20SRC:MED&resulttype=core&format=json

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

10 June 2020

cites work

1 reference

The role of adiponectin in cancer: a review of current evidence

21 January 2018

1 reference

Obesity and cancer risk: evidence, mechanisms, and recommendations

21 January 2018

1 reference

Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue

21 January 2018

1 reference

Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals

21 January 2018

1 reference

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

Resistin: functional roles and therapeutic considerations for cardiovascular disease

21 January 2018

1 reference

Human resistin in cardiovascular disease

21 January 2018

1 reference

Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding proteins

21 January 2018

1 reference

The role of resistin as a regulator of inflammation: Implications for various human pathologies

21 January 2018

1 reference

Resistin competes with lipopolysaccharide for binding to toll-like receptor 4

21 January 2018

1 reference

Activation of SOCS-3 by resistin

21 January 2018

1 reference

Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts

21 January 2018

1 reference

Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters

21 January 2018

1 reference

Leptin, soluble leptin receptor, adiponectin and resistin in relation to OGTT in overweight/obese postmenopausal women

21 January 2018

1 reference

Genome-wide association analysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistin levels

21 January 2018

1 reference

Relationship of serum adiponectin and resistin levels with breast cancer risk

21 January 2018

1 reference

Adipocytokine resistin and breast cancer risk

21 January 2018

1 reference

Hyperresistinemia is associated with postmenopausal breast cancer.

21 January 2018

1 reference

Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk?

21 January 2018

1 reference

Relationship of resistin levels with endometrial cancer risk.

21 January 2018

1 reference

Adipokines and ghrelin in gastric cancer cachexia

21 January 2018

1 reference

Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer.

21 January 2018

1 reference

Adipocytokines and squamous cell carcinoma of the esophagus.

21 January 2018

1 reference

Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients.

21 January 2018

1 reference

Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.

21 January 2018

1 reference

Association between adiponectin, resistin, insulin resistance, and colorectal tumors.

21 January 2018

1 reference

Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer

21 January 2018

1 reference

The role of resistin in colorectal cancer.

21 January 2018

1 reference

Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls

21 January 2018

1 reference

The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study

21 January 2018

1 reference

Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma

21 January 2018

1 reference

Resistin expression in breast cancer tissue as a marker of prognosis and hormone therapy stratification.

21 January 2018

1 reference

Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock.

21 January 2018

1 reference

Obesity-driven inflammation and colorectal cancer.

21 January 2018

1 reference

Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives.

21 January 2018

1 reference

Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.

21 January 2018

1 reference

Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.

21 January 2018

1 reference

Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection

21 January 2018

1 reference

Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation

21 January 2018

1 reference

Genetic variation in adipokine genes and risk of colorectal cancer.

21 January 2018

1 reference

Adipokines linking obesity with colorectal cancer risk in postmenopausal women

21 January 2018

1 reference

Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers

21 January 2018

1 reference

Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study

21 January 2018

1 reference

Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways.

21 January 2018

1 reference

Cloning and functional characterization of resistin-like molecule gamma

21 January 2018

1 reference

Adipokine resistin promotes in vitro angiogenesis of human endothelial cells

21 January 2018

1 reference

Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes

21 January 2018

1 reference

Plasma levels of resistin-like molecule beta in humans.

21 January 2018

1 reference

Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals

21 January 2018

1 reference

Effects of resistin-like molecule β over-expression on gastric cancer cells in vitro

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.13.99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325232%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference